Andres
Iñiguez Romo
![Foto de Andres](/img/nophoto.png)
![Foto de Hospital Álvaro Cunqueiro](/img/noimage_org.png)
Hospital Álvaro Cunqueiro
Vigo, EspañaPublicacións en colaboración con investigadores/as de Hospital Álvaro Cunqueiro (34)
2024
-
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial
European Journal of Internal Medicine, Vol. 126, pp. 89-94
-
Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 7, pp. 890-903
2023
-
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
American Journal of Cardiology, Vol. 190, pp. 32-40
-
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study
American Heart Journal, Vol. 264, pp. 72-82
2022
-
A Score to Assess Mortality After Percutaneous Mitral Valve Repair
Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573
-
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk
Journal of the American College of Cardiology, Vol. 80, Núm. 13, pp. 1220-1237
-
Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial
Journal of the American Heart Association, Vol. 11, Núm. 23
-
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973
2021
-
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178
-
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
Circulation, Vol. 144, Núm. 15, pp. 1196-1211
-
Dual antiplatelet therapy after PCI in patients at high bleeding risk
New England Journal of Medicine, Vol. 385, Núm. 18, pp. 1643-1655
-
Impact of coronary lesion complexity in percutaneous coronary intervention: One-year outcomes from the large, multicentre e-Ultimaster registry
EuroIntervention, Vol. 16, Núm. 7, pp. 603-612
-
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 797-804
2020
-
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry
IJC Heart and Vasculature, Vol. 31
-
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
Cardiovascular Revascularization Medicine, Vol. 21, Núm. 12, pp. 1542-1547
-
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration
International Journal of Cardiology, Vol. 307, pp. 17-23
-
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial
EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921
-
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)
American Journal of Cardiology, Vol. 127, pp. 1-8